Dual Modulation of Sigma-1 and NMDA Receptors in the Treatment of Schizophrenia

Abroad (travel likely)RecruitingPHASE2

Conditions

Schizophrenia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Department of Psychiatry, China Medical University Hospital, Taichung, Taiwan
Contact: Study coordinator (Hsien-Yuan Lane, M.D., Ph.D) · hylane@gmail.com · 886 4 22052121

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia

Schizophrenia

Abroad (travel likely)RecruitingPHASE3

Bryant, United States · Little Rock, United States

TIS for Improving Cognitive Impairment Associated With Schizophrenia

Cognitive Impairment Associated With Schizophrenia (CIAS)

Abroad (travel likely)Recruiting

Changsha, China

MicroRNAs as Biomarkers in First Episode Schizophrenia

Schizophrenia Disorder · Schizophreniform Disorder · Schizoaffective Disorder

Abroad (travel likely)Recruiting

Glen Oaks, United States

tACS for Working Memory in Schizophrenia

Schizophrenia · Working Memory

Abroad (travel likely)Recruiting

Changsha, China